Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Maria-Pia Tuset und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Hearing Research and Cochlear Implant Laboratory, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Dexamethasone, Cochlear Implantation, Cochlear Implants, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: MED-EL GmBh.
Abstract (Originalsprache)
Objectives
This study aims to assess the feasibility and safety of a cochlear catheter (cannula) for inner ear drug delivery during cochlear implantation. We evaluated the otoprotective effect of L‐N‐acetylcysteine (L‐NAC) administered via a cannula in combination with a dexamethasone‐eluting cochlear implant (CI). Study Design An animal model study.
Setting
Animal facility of an academic institution.
Methods
Animals were divided into 8 groups: (1) implantation with a CI; (2) implantation with a dexamethasone‐eluting CI (CIDexel); (3) cannula injection of artificial perilymph (Can+AP); (4) cannula injection of Ringer (Can+R); (5) cannula injection of R and CI (Can+CI); (6) cannula injection of R and Dexel (Can+Dexel); (7) cannula injection of 2 mM L‐NAC and CI (Can L‐NAC 2 mM+CI); or (8) cannula injection of 2mM L‐NAC and Dexel (Can L‐NAC 2 mM++Dexel). The contralateral ear served as the control group. Hearing thresholds were determined preoperatively, and at postoperative day (POD 7) and POD 30 post‐cochlear implantation, using auditory brainstem responses (ABRs). The organ of Corti dissections were performed at POD 30 for hair cell (HC) viability, and oxidative stress assessment using immunostaining.
Results
The L‐NAC (2 mM) and dexamethasone‐eluting electrode group had significantly lower hearing thresholds than the standard CI, Can L‐NAC 2 mM, and Dexel groups. The animal group treated with L‐NAC (2 mM) and dexamethasone‐eluting electrode showed higher HC viability and reduced oxidative stress.
Conclusion
An intracochlear cannula can deliver pharmaceutical interventions without causing additional hearing loss. L‐NAC presents strong anti‐apoptotic potential and administration through a cannula together with Dexel implantation, and achieves a synergistic effect enhancing the otoprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Hearing Research and Cochlear Implant Laboratory, University of Miami Miller School of Medicine, Miami, Florida, USA.
- MED-El GmBh, Innsbruck, Austria.
- Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Department of Biomedical Engineering, University of Miami, Coral Gables, Florida, USA.
- Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida, USA.
Förderung
- MED-EL GmBh
Zitieren
APA
Tuset, M. P., Cooper, J. N., Ebode, D., Mittal, J., Garnham, C., Melchionna, T., Hessler, R., Schilp, S., Godur, D., McKenna, K., Mittal, R., & Eshraghi, A. A. (2025). Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1252
Vancouver
Tuset MP, Cooper JN, Ebode D, Mittal J, Garnham C, Melchionna T, et al. Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1252
BibTeX
@article{Tuset2025,
author = {Tuset, Maria-Pia and Cooper, Jaimee N and Ebode, Dario and Mittal, Jeenu and Garnham, Carolyn and Melchionna, Teresa and Hessler, Roland and Schilp, Sören and Godur, Dimitri and McKenna, Keelin and Mittal, Rahul and Eshraghi, Adrien A},
title = {Intracochlear Drug Delivery Using a Catheter and Dexamethasone‐Eluting Electrode Preserves Residual Hearing Post‐Cochlear Implantation},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1252}
}
EUVIMED